Literature DB >> 22182375

Fluorescence diagnostics as a guide for demarcation and biopsy of suspected anal cancer.

Martin Kriz1, Juraj Hegyi, Thomas Ruzicka, Carola Berking.   

Abstract

BACKGROUND: Malignant epithelial tumors of the perianal skin are relatively rare however show high recurrence rates. A preoperative precise diagnosis and demarcation of the involved cancerous skin remains challenging but is worthwhile to minimize tissue defects and possible limitations of quality of life.
OBJECTIVES: To show the use of fluorescence diagnostics (FD) in the management of chronic perianal disease.
METHODS: FD was performed using methylaminolevulinate (MAL) for three hours topically followed by visualization with blue light (405 nm).
RESULTS: We report on two patients in whom FD helped to demarcate the involved tissue or to direct biopsy to ascertain the final diagnosis. In one patient with a history of Bowen's disease and recurrent anal carcinoma, biopsy showed extramammary Paget's disease and thus was treated by surgical anoplasty. The other patient had a history of chronic anal eczema, and FD-directed biopsy could exclude suspected malignancy so that the anal eczema was treated by local therapy.
CONCLUSIONS: FD is a non-invasive technique which can be used in the perianal region in order to delineate pathologic processes which may reduce the number of surgical interventions.
© 2012 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22182375     DOI: 10.1111/j.1365-4632.2011.04951.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  1 in total

1.  Utility of photodynamic diagnosis plus reflectance confocal microscopy in detecting the margins of extramammary Paget disease.

Authors:  Minzhi Wu; Liming Huang; Xinfeng Lu; Jingjing Li; Yan Wang; Jie Zang; Xingfan Mo; Xuebao Shao; Lili Wang; Wei Cheng; Fanghua He; Qian Zhang; Wei Zhang; Liang Zhao
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Mar-Apr       Impact factor: 2.545

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.